NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
April 17, 2007 • Volume 4 / Number 15 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

University of Michigan Hosts Town Hall Meeting: Stopping Cancer Before It Starts

On April 11, the nonprofit Friends of Cancer Research and the University of Michigan (U-M) Comprehensive Cancer Center hosted a town hall meeting on what the most promising new developments in cancer prevention and detection research will mean for the public.

NCI Director Dr. John E. Niederhuber makes a point at the University of Michigan Town Hall Meeting as Dr. Max Wicha, director of University of Michigan Comprehensive Cancer Center, is in the background. The guest panel, moderated by Susan Dentzer of the NewsHour with Jim Lehrer on PBS-TV, included the Hon. John Dingell (D-MI); NCI Director Dr. John E. Niederhuber; FDA Commissioner Dr. Andrew von Eschenbach; U-M Cancer Center Director Dr. Max Wicha; Dr. Stephen Gruber, director of the Cancer Genetics Clinic at U-M; Dr. Dean Brenner, professor of pharmacology and internal medicine at the U-M School of Medicine; Dr. Joseph Purvis of the pharmaceutical company AstraZeneca; and Ruth Freedman, a long-term breast cancer survivor and volunteer patient counselor at U-M Cancer Center.

Discussion topics ranged from recent findings on how cancer develops and how it may be prevented to how this information may influence clinical trial design, FDA regulation of new products that can prevent and detect cancer, postmarket surveillance, and the financial and other barriers affecting progress in these areas.

A videocast of the meeting is available online at: